Is an NCD the Right Move for Your Technology? Lessons from CMS’s Final Decision on Renal Denervation

Published on: 29/10/2025

Learn when to pursue a National Coverage Determination (NCD) and what CMS’s renal denervation decision means for MedTech reimbursement and evidence strategy.

Payer CoverageEvidence PlanningCommercialization
Is an NCD the Right Move for Your Technology? Lessons from CMS’s Final Decision on Renal Denervation